Key facts
- This page summarizes Jon Halbert's Form 4 filing for Caris Life Sciences, Inc. (CAI).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 27 Feb 2026, 18:08.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
Shares issued in lieu of cash compensation for 2025 board retainer fees. Number of shares determined by dividing the cash retainer earned by the ten trading day average of the daily volume weighted average price per share through and including February 25, 2026.
Footnote F2
The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.
Footnote F3
The 1,250,000 shares previously reported as held indirectly by Ke'Ohana Ventures, LLC were distributed in kind to its members. 625,000 shares were distributed to the Jon and Linda Halbert Management Trust, and 625,000 shares were distributed to LAH Investments, Ltd.